当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 资产负债表

凯普生物

(300639)

  

流通市值:39.83亿  总市值:40.86亿
流通股本:6.30亿   总股本:6.47亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金721,445,496.45768,349,878.89798,561,108.59696,757,930.99
  交易性金融资产160,268,268.51182,516,734.46240,150,167.11242,051,885.72
  应收票据及应收账款650,734,198.52667,287,675.91701,398,731.98861,877,293.93
  其中:应收票据2,224,690.984,111,187.864,425,774.613,801,625.83
        应收账款648,509,507.54663,176,488.05696,972,957.37858,075,668.1
  预付款项5,655,032.717,925,646.166,098,137.487,240,873.58
  其他应收款合计14,384,493.8218,243,369.2914,446,249.1512,118,956.95
  其中:应收利息---99,593.98
  存货67,872,848.7570,809,175.3461,856,208.9379,475,140.68
  其他流动资产76,849,120.3372,689,562.8471,594,443.4576,541,397.21
  流动资产合计1,697,209,459.091,787,822,042.891,894,105,046.691,976,063,479.06
非流动资产:
  长期股权投资38,589,260.3438,476,675.6338,927,871.341,261,533.83
  其他权益工具投资506,690,688.75486,374,830.84270,647,610.28288,953,099.3
  其他非流动金融资产232,336,726.33213,990,000222,353,009.38221,250,038.72
  固定资产1,222,013,457.271,252,055,645.951,274,399,145.271,285,652,842.26
  在建工程43,688,685.9232,179,740.8832,183,112.0431,388,924.95
  使用权资产4,479,952.146,609,670.618,036,879.578,511,209.07
  无形资产300,444,303.86249,878,173.3252,703,790.75251,143,380.9
  开发支出29,656,027.132,989,951.330,452,850.7331,458,037.52
  商誉5,099,080.315,099,080.31--
  长期待摊费用25,761,747.823,573,603.8825,551,243.3829,778,950.13
  递延所得税资产60,109,678.9563,518,881.4366,770,674.9875,118,051.7
  其他非流动资产32,765,074.0430,843,997.3431,535,166.9341,826,316.41
  非流动资产合计2,501,634,682.812,435,590,251.472,253,561,354.612,306,342,384.79
  资产总计4,198,844,141.94,223,412,294.364,147,666,401.34,282,405,863.85
流动负债:
  短期借款11,037,655.486,120,337.656,824,682.941,000,527.5
  应付票据及应付账款80,004,458.1390,185,794.686,362,084.9695,033,539.84
        应付账款80,004,458.1390,185,794.686,362,084.9695,033,539.84
  合同负债10,618,446.169,466,740.0710,962,115.8512,569,608.9
  应付职工薪酬43,240,404.8738,957,351.9647,710,126.7462,955,755.11
  应交税费12,224,1086,824,361.1510,104,430.3614,719,556.95
  其他应付款合计153,766,649.5180,440,235.79182,979,364.83197,359,496.64
        应付股利5,226,407.25-5,435,030.28-
  一年内到期的非流动负债3,109,652.994,535,718.666,263,411.095,386,801.29
  其他流动负债1,106,141.28803,106.761,118,908.511,137,703.44
  流动负债合计315,107,516.41337,333,646.64352,325,125.28390,162,989.67
非流动负债:
  长期借款69,228,00073,287,541.1173,240,00095,570,428.6
  租赁负债2,794,479.953,371,314.373,236,171.434,302,543.16
  预计负债1,736,459.912,248,005.662,248,005.66510,962.98
  递延收益6,107,221.026,433,030.826,935,830.187,509,980.96
  递延所得税负债80,316,238.2881,160,000.8847,870,078.1755,705,179.61
  非流动负债合计160,182,399.16166,499,892.84133,530,085.44163,599,095.31
  负债合计475,289,915.57503,833,539.48485,855,210.72553,762,084.98
所有者权益(或股东权益):
  实收资本(或股本)646,500,674646,500,674646,500,674646,500,674
  资本公积642,126,591.04652,959,338.09667,106,546.17726,713,360.67
  减:库存股110,145,478.95110,145,478.95110,145,478.95110,145,478.95
  其他综合收益178,470,953.28199,840,763.08125,097,856.16154,707,976.11
  盈余公积87,555,295.287,555,295.287,555,295.287,555,295.2
  未分配利润2,363,501,288.112,329,442,723.772,332,239,236.212,335,498,364.02
  归属于母公司股东权益合计3,808,009,322.683,806,153,315.193,748,354,128.793,840,830,191.05
  少数股东权益-84,455,096.35-86,574,560.31-86,542,938.21-112,186,412.18
  股东权益合计3,723,554,226.333,719,578,754.883,661,811,190.583,728,643,778.87
  负债和股东权益合计4,198,844,141.94,223,412,294.364,147,666,401.34,282,405,863.85
公告日期2026-08-152026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑